Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Drug Ingredient Testing Service was estimated to be worth US$ 8532 million in 2024 and is forecast to a readjusted size of US$ 12059 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Drug component testing services are a professional chemical analysis service designed to comprehensively analyze the chemical components in pharmaceuticals through a series of sophisticated experimental methods and techniques. This service primarily targets the accurate determination of active ingredients, pharmaceutical excipients, and impurities or contaminants that may be introduced during production or storage. Its core purpose is to ensure drug quality, guarantee patient safety, and meet the legal standards of domestic and international pharmacopoeias. This service is integrated throughout the entire process of drug research and development, production, post-market quality control, and even market supervision, serving as an indispensable technical support in the pharmaceutical industry chain.
Drug Ingredient Testing Service Market Size(US$)
M= millions and B=billions

The pharmaceutical component testing services market is currently experiencing rapid growth with promising future prospects. This growth is primarily driven by increasing demand for biopharmaceutical and complex formulation development, increasingly stringent global pharmaceutical regulations, and the pharmaceutical industry's continuous pursuit of higher product quality and safety standards. Simultaneously, the deep integration of advanced technologies such as automation, artificial intelligence (AI), and cloud computing is significantly improving testing efficiency and data analysis capabilities, injecting new growth momentum into the market. Furthermore, the trend towards personalized medicine is placing new demands on more specialized and sensitive component testing, indicating that this field will continue to innovate and maintain strong growth momentum.
This report aims to provide a comprehensive presentation of the global market for Drug Ingredient Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Ingredient Testing Service by region & country, by Type, and by Application.
The Drug Ingredient Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Ingredient Testing Service.
Market Segmentation
Report Metric
Details
Report Title
Drug Ingredient Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 12059 million
CAGR(2025-2031)
5.1%
Market Size Available for Years
2025-2031
Global Drug Ingredient Testing Service Companies Covered
SGS S.A.
Cotecn
Curia Global
ADPEN Laboratories
Nelson Labs
Almac
Q Laboratories
Creative Proteomics
Eurofins Scientific
CPT Labs
Evans Analytical Group
Vetter Pharma
Tentamus Group
Contract Laboratory
Auriga Research
Global Drug Ingredient Testing Service Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Ingredient Testing Service Market, Segment by Type
Veterinary Drug Testing
Drug Testing
Pesticide Testing
Global Drug Ingredient Testing Service Market, Segment by Application
Drug Research and Development
Quality Control
Clinical Research
Drug Supervision
Others
Product Category
Drug Identification and Content Determination
Impurity Analysis and Solvent Residue Detection
Drug Safety Testing
Market Segment
Raw Material Testing
Microbiological Testing
Pharmaceutical Packaging Material Testing
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Ingredient Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Ingredient Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Ingredient Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Drug Ingredient Testing Service Product Introduction
1.2 Global Drug Ingredient Testing Service Market Size Forecast (2020-2031)
1.3 Drug Ingredient Testing Service Market Trends & Drivers
1.3.1 Drug Ingredient Testing Service Industry Trends
1.3.2 Drug Ingredient Testing Service Market Drivers & Opportunity
1.3.3 Drug Ingredient Testing Service Market Challenges
1.3.4 Drug Ingredient Testing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Ingredient Testing Service Players Revenue Ranking (2024)
2.2 Global Drug Ingredient Testing Service Revenue by Company (2020-2025)
2.3 Key Companies Drug Ingredient Testing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Ingredient Testing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Ingredient Testing Service
2.6 Drug Ingredient Testing Service Market Competitive Analysis
2.6.1 Drug Ingredient Testing Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Drug Ingredient Testing Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Ingredient Testing Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Veterinary Drug Testing
3.1.2 Drug Testing
3.1.3 Pesticide Testing
3.2 Global Drug Ingredient Testing Service Sales Value by Type
3.2.1 Global Drug Ingredient Testing Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Drug Ingredient Testing Service Sales Value, by Type (2020-2031)
3.2.3 Global Drug Ingredient Testing Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Technical Purpose
4.1 Introduction by Technical Purpose
4.1.1 Drug Identification and Content Determination
4.1.2 Impurity Analysis and Solvent Residue Detection
4.1.3 Drug Safety Testing
4.2 Global Drug Ingredient Testing Service Sales Value by Technical Purpose
4.2.1 Global Drug Ingredient Testing Service Sales Value by Technical Purpose (2020 VS 2024 VS 2031)
4.2.2 Global Drug Ingredient Testing Service Sales Value, by Technical Purpose (2020-2031)
4.2.3 Global Drug Ingredient Testing Service Sales Value, by Technical Purpose (%) (2020-2031)
5 Segmentation by Testing Object
5.1 Introduction by Testing Object
5.1.1 Raw Material Testing
5.1.2 Microbiological Testing
5.1.3 Pharmaceutical Packaging Material Testing
5.1.4 Others
5.2 Global Drug Ingredient Testing Service Sales Value by Testing Object
5.2.1 Global Drug Ingredient Testing Service Sales Value by Testing Object (2020 VS 2024 VS 2031)
5.2.2 Global Drug Ingredient Testing Service Sales Value, by Testing Object (2020-2031)
5.2.3 Global Drug Ingredient Testing Service Sales Value, by Testing Object (%) (2020-2031)
6 Segmentation by Application
6.1 Introduction by Application
6.1.1 Drug Research and Development
6.1.2 Quality Control
6.1.3 Clinical Research
6.1.4 Drug Supervision
6.1.5 Others
6.2 Global Drug Ingredient Testing Service Sales Value by Application
6.2.1 Global Drug Ingredient Testing Service Sales Value by Application (2020 VS 2024 VS 2031)
6.2.2 Global Drug Ingredient Testing Service Sales Value, by Application (2020-2031)
6.2.3 Global Drug Ingredient Testing Service Sales Value, by Application (%) (2020-2031)
7 Segmentation by Region
7.1 Global Drug Ingredient Testing Service Sales Value by Region
7.1.1 Global Drug Ingredient Testing Service Sales Value by Region: 2020 VS 2024 VS 2031
7.1.2 Global Drug Ingredient Testing Service Sales Value by Region (2020-2025)
7.1.3 Global Drug Ingredient Testing Service Sales Value by Region (2026-2031)
7.1.4 Global Drug Ingredient Testing Service Sales Value by Region (%), (2020-2031)
7.2 North America
7.2.1 North America Drug Ingredient Testing Service Sales Value, 2020-2031
7.2.2 North America Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
7.3 Europe
7.3.1 Europe Drug Ingredient Testing Service Sales Value, 2020-2031
7.3.2 Europe Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
7.4 Asia Pacific
7.4.1 Asia Pacific Drug Ingredient Testing Service Sales Value, 2020-2031
7.4.2 Asia Pacific Drug Ingredient Testing Service Sales Value by Region (%), 2024 VS 2031
7.5 South America
7.5.1 South America Drug Ingredient Testing Service Sales Value, 2020-2031
7.5.2 South America Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
7.6 Middle East & Africa
7.6.1 Middle East & Africa Drug Ingredient Testing Service Sales Value, 2020-2031
7.6.2 Middle East & Africa Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
8 Segmentation by Key Countries/Regions
8.1 Key Countries/Regions Drug Ingredient Testing Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
8.2 Key Countries/Regions Drug Ingredient Testing Service Sales Value, 2020-2031
8.3 United States
8.3.1 United States Drug Ingredient Testing Service Sales Value, 2020-2031
8.3.2 United States Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.3.3 United States Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
8.4 Europe
8.4.1 Europe Drug Ingredient Testing Service Sales Value, 2020-2031
8.4.2 Europe Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.4.3 Europe Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
8.5 China
8.5.1 China Drug Ingredient Testing Service Sales Value, 2020-2031
8.5.2 China Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.5.3 China Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
8.6 Japan
8.6.1 Japan Drug Ingredient Testing Service Sales Value, 2020-2031
8.6.2 Japan Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.6.3 Japan Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Drug Ingredient Testing Service Sales Value, 2020-2031
8.7.2 South Korea Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.7.3 South Korea Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Drug Ingredient Testing Service Sales Value, 2020-2031
8.8.2 Southeast Asia Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.8.3 Southeast Asia Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
8.9 India
8.9.1 India Drug Ingredient Testing Service Sales Value, 2020-2031
8.9.2 India Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
8.9.3 India Drug Ingredient Testing Service Sales Value by Application, 2024 VS 2031
9 Company Profiles
9.1 SGS S.A.
9.1.1 SGS S.A. Profile
9.1.2 SGS S.A. Main Business
9.1.3 SGS S.A. Drug Ingredient Testing Service Products, Services and Solutions
9.1.4 SGS S.A. Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.1.5 SGS S.A. Recent Developments
9.2 Cotecn
9.2.1 Cotecn Profile
9.2.2 Cotecn Main Business
9.2.3 Cotecn Drug Ingredient Testing Service Products, Services and Solutions
9.2.4 Cotecn Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.2.5 Cotecn Recent Developments
9.3 Curia Global
9.3.1 Curia Global Profile
9.3.2 Curia Global Main Business
9.3.3 Curia Global Drug Ingredient Testing Service Products, Services and Solutions
9.3.4 Curia Global Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.3.5 Curia Global Recent Developments
9.4 ADPEN Laboratories
9.4.1 ADPEN Laboratories Profile
9.4.2 ADPEN Laboratories Main Business
9.4.3 ADPEN Laboratories Drug Ingredient Testing Service Products, Services and Solutions
9.4.4 ADPEN Laboratories Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.4.5 ADPEN Laboratories Recent Developments
9.5 Nelson Labs
9.5.1 Nelson Labs Profile
9.5.2 Nelson Labs Main Business
9.5.3 Nelson Labs Drug Ingredient Testing Service Products, Services and Solutions
9.5.4 Nelson Labs Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.5.5 Nelson Labs Recent Developments
9.6 Almac
9.6.1 Almac Profile
9.6.2 Almac Main Business
9.6.3 Almac Drug Ingredient Testing Service Products, Services and Solutions
9.6.4 Almac Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.6.5 Almac Recent Developments
9.7 Q Laboratories
9.7.1 Q Laboratories Profile
9.7.2 Q Laboratories Main Business
9.7.3 Q Laboratories Drug Ingredient Testing Service Products, Services and Solutions
9.7.4 Q Laboratories Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.7.5 Q Laboratories Recent Developments
9.8 Creative Proteomics
9.8.1 Creative Proteomics Profile
9.8.2 Creative Proteomics Main Business
9.8.3 Creative Proteomics Drug Ingredient Testing Service Products, Services and Solutions
9.8.4 Creative Proteomics Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.8.5 Creative Proteomics Recent Developments
9.9 Eurofins Scientific
9.9.1 Eurofins Scientific Profile
9.9.2 Eurofins Scientific Main Business
9.9.3 Eurofins Scientific Drug Ingredient Testing Service Products, Services and Solutions
9.9.4 Eurofins Scientific Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.9.5 Eurofins Scientific Recent Developments
9.10 CPT Labs
9.10.1 CPT Labs Profile
9.10.2 CPT Labs Main Business
9.10.3 CPT Labs Drug Ingredient Testing Service Products, Services and Solutions
9.10.4 CPT Labs Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.10.5 CPT Labs Recent Developments
9.11 Evans Analytical Group
9.11.1 Evans Analytical Group Profile
9.11.2 Evans Analytical Group Main Business
9.11.3 Evans Analytical Group Drug Ingredient Testing Service Products, Services and Solutions
9.11.4 Evans Analytical Group Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.11.5 Evans Analytical Group Recent Developments
9.12 Vetter Pharma
9.12.1 Vetter Pharma Profile
9.12.2 Vetter Pharma Main Business
9.12.3 Vetter Pharma Drug Ingredient Testing Service Products, Services and Solutions
9.12.4 Vetter Pharma Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.12.5 Vetter Pharma Recent Developments
9.13 Tentamus Group
9.13.1 Tentamus Group Profile
9.13.2 Tentamus Group Main Business
9.13.3 Tentamus Group Drug Ingredient Testing Service Products, Services and Solutions
9.13.4 Tentamus Group Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.13.5 Tentamus Group Recent Developments
9.14 Contract Laboratory
9.14.1 Contract Laboratory Profile
9.14.2 Contract Laboratory Main Business
9.14.3 Contract Laboratory Drug Ingredient Testing Service Products, Services and Solutions
9.14.4 Contract Laboratory Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.14.5 Contract Laboratory Recent Developments
9.15 Auriga Research
9.15.1 Auriga Research Profile
9.15.2 Auriga Research Main Business
9.15.3 Auriga Research Drug Ingredient Testing Service Products, Services and Solutions
9.15.4 Auriga Research Drug Ingredient Testing Service Revenue (US$ Million) & (2020-2025)
9.15.5 Auriga Research Recent Developments
10 Industry Chain Analysis
10.1 Drug Ingredient Testing Service Industrial Chain
10.2 Drug Ingredient Testing Service Upstream Analysis
10.2.1 Key Raw Materials
10.2.2 Raw Materials Key Suppliers
10.2.3 Manufacturing Cost Structure
10.3 Midstream Analysis
10.4 Downstream Analysis (Customers Analysis)
10.5 Sales Model and Sales Channels
10.5.1 Drug Ingredient Testing Service Sales Model
10.5.2 Sales Channel
10.5.3 Drug Ingredient Testing Service Distributors
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Drug Ingredient Testing Service Market Trends
Table 2. Drug Ingredient Testing Service Market Drivers & Opportunity
Table 3. Drug Ingredient Testing Service Market Challenges
Table 4. Drug Ingredient Testing Service Market Restraints
Table 5. Global Drug Ingredient Testing Service Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Drug Ingredient Testing Service Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Drug Ingredient Testing Service Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drug Ingredient Testing Service Product Type
Table 9. Key Companies Time to Begin Mass Production of Drug Ingredient Testing Service
Table 10. Global Drug Ingredient Testing Service Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Ingredient Testing Service as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drug Ingredient Testing Service Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Drug Ingredient Testing Service Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Drug Ingredient Testing Service Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Drug Ingredient Testing Service Sales Market Share in Value by Type (2020-2025)
Table 17. Global Drug Ingredient Testing Service Sales Market Share in Value by Type (2026-2031)
Table 18. Global Drug Ingredient Testing Service Sales Value by Technical Purpose: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Drug Ingredient Testing Service Sales Value by Technical Purpose (2020-2025) & (US$ Million)
Table 20. Global Drug Ingredient Testing Service Sales Value by Technical Purpose (2026-2031) & (US$ Million)
Table 21. Global Drug Ingredient Testing Service Sales Market Share in Value by Technical Purpose (2020-2025)
Table 22. Global Drug Ingredient Testing Service Sales Market Share in Value by Technical Purpose (2026-2031)
Table 23. Global Drug Ingredient Testing Service Sales Value by Testing Object: 2020 VS 2024 VS 2031 (US$ Million)
Table 24. Global Drug Ingredient Testing Service Sales Value by Testing Object (2020-2025) & (US$ Million)
Table 25. Global Drug Ingredient Testing Service Sales Value by Testing Object (2026-2031) & (US$ Million)
Table 26. Global Drug Ingredient Testing Service Sales Market Share in Value by Testing Object (2020-2025)
Table 27. Global Drug Ingredient Testing Service Sales Market Share in Value by Testing Object (2026-2031)
Table 28. Global Drug Ingredient Testing Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Drug Ingredient Testing Service Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Drug Ingredient Testing Service Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Drug Ingredient Testing Service Sales Market Share in Value by Application (2020-2025)
Table 32. Global Drug Ingredient Testing Service Sales Market Share in Value by Application (2026-2031)
Table 33. Global Drug Ingredient Testing Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 34. Global Drug Ingredient Testing Service Sales Value by Region (2020-2025) & (US$ Million)
Table 35. Global Drug Ingredient Testing Service Sales Value by Region (2026-2031) & (US$ Million)
Table 36. Global Drug Ingredient Testing Service Sales Value by Region (2020-2025) & (%)
Table 37. Global Drug Ingredient Testing Service Sales Value by Region (2026-2031) & (%)
Table 38. Key Countries/Regions Drug Ingredient Testing Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 39. Key Countries/Regions Drug Ingredient Testing Service Sales Value, (2020-2025) & (US$ Million)
Table 40. Key Countries/Regions Drug Ingredient Testing Service Sales Value, (2026-2031) & (US$ Million)
Table 41. SGS S.A. Basic Information List
Table 42. SGS S.A. Description and Business Overview
Table 43. SGS S.A. Drug Ingredient Testing Service Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drug Ingredient Testing Service Business of SGS S.A. (2020-2025)
Table 45. SGS S.A. Recent Developments
Table 46. Cotecn Basic Information List
Table 47. Cotecn Description and Business Overview
Table 48. Cotecn Drug Ingredient Testing Service Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Cotecn (2020-2025)
Table 50. Cotecn Recent Developments
Table 51. Curia Global Basic Information List
Table 52. Curia Global Description and Business Overview
Table 53. Curia Global Drug Ingredient Testing Service Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Curia Global (2020-2025)
Table 55. Curia Global Recent Developments
Table 56. ADPEN Laboratories Basic Information List
Table 57. ADPEN Laboratories Description and Business Overview
Table 58. ADPEN Laboratories Drug Ingredient Testing Service Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drug Ingredient Testing Service Business of ADPEN Laboratories (2020-2025)
Table 60. ADPEN Laboratories Recent Developments
Table 61. Nelson Labs Basic Information List
Table 62. Nelson Labs Description and Business Overview
Table 63. Nelson Labs Drug Ingredient Testing Service Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Nelson Labs (2020-2025)
Table 65. Nelson Labs Recent Developments
Table 66. Almac Basic Information List
Table 67. Almac Description and Business Overview
Table 68. Almac Drug Ingredient Testing Service Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Almac (2020-2025)
Table 70. Almac Recent Developments
Table 71. Q Laboratories Basic Information List
Table 72. Q Laboratories Description and Business Overview
Table 73. Q Laboratories Drug Ingredient Testing Service Products, Services and Solutions
Table 74. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Q Laboratories (2020-2025)
Table 75. Q Laboratories Recent Developments
Table 76. Creative Proteomics Basic Information List
Table 77. Creative Proteomics Description and Business Overview
Table 78. Creative Proteomics Drug Ingredient Testing Service Products, Services and Solutions
Table 79. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Creative Proteomics (2020-2025)
Table 80. Creative Proteomics Recent Developments
Table 81. Eurofins Scientific Basic Information List
Table 82. Eurofins Scientific Description and Business Overview
Table 83. Eurofins Scientific Drug Ingredient Testing Service Products, Services and Solutions
Table 84. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Eurofins Scientific (2020-2025)
Table 85. Eurofins Scientific Recent Developments
Table 86. CPT Labs Basic Information List
Table 87. CPT Labs Description and Business Overview
Table 88. CPT Labs Drug Ingredient Testing Service Products, Services and Solutions
Table 89. Revenue (US$ Million) in Drug Ingredient Testing Service Business of CPT Labs (2020-2025)
Table 90. CPT Labs Recent Developments
Table 91. Evans Analytical Group Basic Information List
Table 92. Evans Analytical Group Description and Business Overview
Table 93. Evans Analytical Group Drug Ingredient Testing Service Products, Services and Solutions
Table 94. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Evans Analytical Group (2020-2025)
Table 95. Evans Analytical Group Recent Developments
Table 96. Vetter Pharma Basic Information List
Table 97. Vetter Pharma Description and Business Overview
Table 98. Vetter Pharma Drug Ingredient Testing Service Products, Services and Solutions
Table 99. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Vetter Pharma (2020-2025)
Table 100. Vetter Pharma Recent Developments
Table 101. Tentamus Group Basic Information List
Table 102. Tentamus Group Description and Business Overview
Table 103. Tentamus Group Drug Ingredient Testing Service Products, Services and Solutions
Table 104. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Tentamus Group (2020-2025)
Table 105. Tentamus Group Recent Developments
Table 106. Contract Laboratory Basic Information List
Table 107. Contract Laboratory Description and Business Overview
Table 108. Contract Laboratory Drug Ingredient Testing Service Products, Services and Solutions
Table 109. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Contract Laboratory (2020-2025)
Table 110. Contract Laboratory Recent Developments
Table 111. Auriga Research Basic Information List
Table 112. Auriga Research Description and Business Overview
Table 113. Auriga Research Drug Ingredient Testing Service Products, Services and Solutions
Table 114. Revenue (US$ Million) in Drug Ingredient Testing Service Business of Auriga Research (2020-2025)
Table 115. Auriga Research Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Drug Ingredient Testing Service Downstream Customers
Table 119. Drug Ingredient Testing Service Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Ingredient Testing Service Product Picture
Figure 2. Global Drug Ingredient Testing Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Drug Ingredient Testing Service Sales Value (2020-2031) & (US$ Million)
Figure 4. Drug Ingredient Testing Service Report Years Considered
Figure 5. Global Drug Ingredient Testing Service Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Drug Ingredient Testing Service Revenue in 2024
Figure 7. Drug Ingredient Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Veterinary Drug Testing Picture
Figure 9. Drug Testing Picture
Figure 10. Pesticide Testing Picture
Figure 11. Global Drug Ingredient Testing Service Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Drug Ingredient Testing Service Sales Value Market Share by Type, 2024 & 2031
Figure 13. Drug Identification and Content Determination Picture
Figure 14. Impurity Analysis and Solvent Residue Detection Picture
Figure 15. Drug Safety Testing Picture
Figure 16. Global Drug Ingredient Testing Service Sales Value by Technical Purpose (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Drug Ingredient Testing Service Sales Value Market Share by Technical Purpose, 2024 & 2031
Figure 18. Raw Material Testing Picture
Figure 19. Microbiological Testing Picture
Figure 20. Pharmaceutical Packaging Material Testing Picture
Figure 21. Others Picture
Figure 22. Global Drug Ingredient Testing Service Sales Value by Testing Object (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Drug Ingredient Testing Service Sales Value Market Share by Testing Object, 2024 & 2031
Figure 24. Product Picture of Drug Research and Development
Figure 25. Product Picture of Quality Control
Figure 26. Product Picture of Clinical Research
Figure 27. Product Picture of Drug Supervision
Figure 28. Product Picture of Others
Figure 29. Global Drug Ingredient Testing Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 30. Global Drug Ingredient Testing Service Sales Value Market Share by Application, 2024 & 2031
Figure 31. North America Drug Ingredient Testing Service Sales Value (2020-2031) & (US$ Million)
Figure 32. North America Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 33. Europe Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 35. Asia Pacific Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Drug Ingredient Testing Service Sales Value by Region (%), 2024 VS 2031
Figure 37. South America Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 38. South America Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 39. Middle East & Africa Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 40. Middle East & Africa Drug Ingredient Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 41. Key Countries/Regions Drug Ingredient Testing Service Sales Value (%), (2020-2031)
Figure 42. United States Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 43. United States Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 44. United States Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 45. Europe Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 46. Europe Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 47. Europe Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 48. China Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 49. China Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 50. China Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 51. Japan Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 52. Japan Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 53. Japan Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 54. South Korea Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 55. South Korea Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 56. South Korea Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 57. Southeast Asia Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 58. Southeast Asia Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 59. Southeast Asia Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 60. India Drug Ingredient Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 61. India Drug Ingredient Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 62. India Drug Ingredient Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 63. Drug Ingredient Testing Service Industrial Chain
Figure 64. Drug Ingredient Testing Service Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives InterviewedDescription
The global market for Drug Ingredient Testing Service was estimated to be worth US$ 8532 million in 2024 and is forecast to a readjusted size of US$ 12059 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Drug component testing services are a professional chemical analysis service designed to comprehensively analyze the chemical components in pharmaceuticals through a series of sophisticated experimental methods and techniques. This service primarily targets the accurate determination of active ingredients, pharmaceutical excipients, and impurities or contaminants that may be introduced during production or storage. Its core purpose is to ensure drug quality, guarantee patient safety, and meet the legal standards of domestic and international pharmacopoeias. This service is integrated throughout the entire process of drug research and development, production, post-market quality control, and even market supervision, serving as an indispensable technical support in the pharmaceutical industry chain.
The pharmaceutical component testing services market is currently experiencing rapid growth with promising future prospects. This growth is primarily driven by increasing demand for biopharmaceutical and complex formulation development, increasingly stringent global pharmaceutical regulations, and the pharmaceutical industry's continuous pursuit of higher product quality and safety standards. Simultaneously, the deep integration of advanced technologies such as automation, artificial intelligence (AI), and cloud computing is significantly improving testing efficiency and data analysis capabilities, injecting new growth momentum into the market. Furthermore, the trend towards personalized medicine is placing new demands on more specialized and sensitive component testing, indicating that this field will continue to innovate and maintain strong growth momentum.
This report aims to provide a comprehensive presentation of the global market for Drug Ingredient Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Ingredient Testing Service by region & country, by Type, and by Application.
The Drug Ingredient Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Ingredient Testing Service.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Ingredient Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Ingredient Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Ingredient Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
The global Drug Ingredient Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 91
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Drug Ingredient Testing Service Market
Published: 2024-04-26
Pages: 113
USD 4900.00
(Single User License)
The global market for Drug Ingredient Testing Service was valued at US$ 8532 million in the year 2024 and is projected to reach a revised size of US$ 12059 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-11-28
Pages: 81
USD 2900.00
(Single User License)
The global market for Drug Ingredient Testing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 132
USD 3950.00
(Single User License)
The global Drug Ingredient Testing Service market size was US$ 8532 million in 2024 and is forecast to a readjusted size of US$ 12059 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-28
Pages: 97
USD 4250.00
(Single User License)
The global Drug Ingredient Testing Service market is projected to grow from US$ 8532 million in 2024 to US$ 12059 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-28
Pages: 132
USD 4900.00
(Single User License)
The global Drug Ingredient Testing Service market was valued at US$ 8947 million in 2025 and is anticipated to reach US$ 12610 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
USD 2900.00
(Single User License)
The global market for Drug Ingredient Testing Service was estimated to be worth US$ 8947 million in 2025 and is projected to reach US$ 12610 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-11
Pages: 117
USD 3950.00
(Single User License)
The global Drug Ingredient Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 91
Market Analysis and Insights: Global Drug Ingredient Testing Service Market
Published: 2024-04-26
Pages: 113
The global market for Drug Ingredient Testing Service was valued at US$ 8532 million in the year 2024 and is projected to reach a revised size of US$ 12059 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-11-28
Pages: 81
The global market for Drug Ingredient Testing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 132
The global Drug Ingredient Testing Service market size was US$ 8532 million in 2024 and is forecast to a readjusted size of US$ 12059 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-28
Pages: 97
The global Drug Ingredient Testing Service market is projected to grow from US$ 8532 million in 2024 to US$ 12059 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-28
Pages: 132
The global Drug Ingredient Testing Service market was valued at US$ 8947 million in 2025 and is anticipated to reach US$ 12610 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
The global market for Drug Ingredient Testing Service was estimated to be worth US$ 8947 million in 2025 and is projected to reach US$ 12610 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-11
Pages: 117
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database